SGLT2 inhibitor is administered once a day for 6 months.

2 trials

Sponsors

Tokyo Women's Medical University School of Medicine, Kitasato University School of Medicine

Conditions

Diabetic patients after kidney transplantDiabetic patients with chronic liver disease

Unknown Phase

Efficacy and safety of sodium-glucose co-transporter (SGLT2) inhibitor in diabetic patients post renal transplantation

RecruitingJPRN-UMIN000033628

Tokyo Women's Medical University School of MedicineDiabetic patients after kidney transplant

Start: 2018-03-01Target: 15Updated: 2026-06-29

Efficacy and safety of sodium-glucose co-transporter (SGLT2) inhibitor in diabetic patients with chronic liver disease

RecruitingJPRN-UMIN000035015

Kitasato University School of MedicineDiabetic patients with chronic liver disease

Start: 2018-12-10Target: 100Updated: 2026-06-29